Article (Scientific journals)
Epidemiology and Control of Fox Rabies in Europe
Pastoret, Paul-Pierre; Brochier, B.
1999In Vaccine, 17 (13-14), p. 1750-4
Peer Reviewed verified by ORBi
 

Files


Full Text
31 ok.pdf
Author postprint (199.06 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Abstract :
[en] During recent years, most of the research on the control of sylvatic rabies has concentrated on developing methods of oral vaccination of wild rabies vectors. In order to improve both the safety and the stability of the vaccine used, a recombinant vaccinia virus which expresses the immunizing glycoprotein of rabies virus (VRG) has been developed and extensively tested in the laboratory as well as in the field. From 1989 until 1995, several million VRG vaccine doses have been dispersed in western Europe for vaccination of red foxes. In Europe, the use of VRG has lead to the elimination of sylvatic rabies from large areas, which have consequently been freed from vaccination. This may have consequences on the regulation of pets movements within the whole European Union.
Disciplines :
Veterinary medicine & animal health
Author, co-author :
Pastoret, Paul-Pierre ;  Université de Liège - ULiège > Faculté de médecine vétérinaire > Immunology/Vaccinology
Brochier, B.;  Université de Liège - ULiège
Language :
English
Title :
Epidemiology and Control of Fox Rabies in Europe
Publication date :
26 March 1999
Journal title :
Vaccine
ISSN :
0264-410X
eISSN :
1873-2518
Publisher :
Elsevier, Netherlands
Volume :
17
Issue :
13-14
Pages :
1750-4
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 21 January 2021

Statistics


Number of views
258 (0 by ULiège)
Number of downloads
171 (0 by ULiège)

Scopus citations®
 
78
Scopus citations®
without self-citations
75
OpenCitations
 
60

Bibliography


Similar publications



Contact ORBi